The CBFA2T3-GLIS2 (C/G) fusion is a product of a cryptic translocation primarily seen in infants and early childhood and is associated with dismal outcome. Here, we demonstrate that the expression of the C/G oncogenic fusion protein promotes the transformation of human cord blood hematopoietic stem and progenitor cells (CB HSPCs) in an endothelial cell coculture system that recapitulates the transcriptome, morphology, and immunophenotype of C/G acute myeloid leukemia (AML) and induces highly aggressive leukemia in xenograft models. Interrogating the transcriptome of C/G-CB cells and primary C/G AML identified a library of C/G-fusion-specific genes that are potential targets for therapy. We developed chimeric antigen receptor (CAR) T cells directed against one of the targets, folate receptor α (FOLR1), and demonstrated their preclinical efficacy against C/G AML using in vitro and xenograft models. FOLR1 is also expressed in renal and pulmonary epithelium, raising concerns for toxicity that must be addressed for the clinical application of this therapy. Our findings underscore the role of the endothelial niche in promoting leukemic transformation of C/G-transduced CB HSPCs. Furthermore, this work has broad implications for studies of leukemogenesis applicable to a variety of oncogenic fusion-driven pediatric leukemias, providing a robust and tractable model system to characterize the molecular mechanisms of leukemogenesis and identify biomarkers for disease diagnosis and targets for therapy.
Quy Le, Brandon Hadland, Jenny L. Smith, Amanda Leonti, Benjamin J. Huang, Rhonda Ries, Tiffany A. Hylkema, Sommer Castro, Thao T. Tang, Cyd N. McKay, LaKeisha Perkins, Laura Pardo, Jay Sarthy, Amy K. Beckman, Robin Williams, Rhonda Idemmili, Scott Furlan, Takashi Ishida, Lindsey Call, Shivani Srivastava, Anisha M. Loeb, Filippo Milano, Suzan Imren, Shelli M. Morris, Fiona Pakiam, Jim M. Olson, Michael R. Loken, Lisa Brodersen, Stanley R. Riddell, Katherine Tarlock, Irwin D. Bernstein, Keith R. Loeb, Soheil Meshinchi
Title and authors | Publication | Year |
---|---|---|
Folate metabolism in myelofibrosis: a missing key?
Cerreto GM, Pozzi G, Cortellazzi S, Pasini LM, Di Martino O, Mirandola P, Carubbi C, Vitale M, Masselli E |
Annals of Hematology | 2025 |
Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene
Du Y, Yang L, Qi S, Chen Z, Sun M, Wu M, Wu B, Tao F, Xiong H |
Journal of Pediatric Hematology/Oncology | 2024 |
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children’s Hospital at Baylor College of Medicine
Stevens AM, Terrell M, Rashid R, Fisher KE, Marcogliese AN, Gaikwad A, Rao P, Vrana C, Krueger M, Loken M, Menssen AJ, Cook JA, Keogh N, Alozie M, Oviedo H, Gonzalez AK, Ilangovan T, Kim J, Sandhu S, Redell MS |
Biomedicines | 2024 |
Rare Hematologic Malignancies and Pre-Leukemic Entities in Children and Adolescents Young Adults
Brown A, Batra S |
Cancers | 2024 |
CBFA2T3 Is PPARA Sensitive and Attenuates Fasting-Induced Lipid Accumulation in Mouse Liver
Kim D, Ha SK, Gonzalez FJ |
Cells | 2024 |
Venetoclax: a new player in the treatment of children with high-risk myeloid malignancies?
Masetti R, Baccelli F, Leardini D, Locatelli F |
Blood Advances | 2024 |
Developmental interplay between transcriptional alterations and a targetable cytokine signaling dependency in pediatric ETO2::GLIS2 leukemia.
Alonso-Pérez V, Galant K, Boudia F, Robert E, Aid Z, Renou L, Barroca V, Devanand S, Babin L, Rouiller-Fabre V, Moison D, Busso D, Piton G, Metereau C, Abermil N, Ballerini P, Hirsch P, Haddad R, Martinovic J, Petit A, Lapillonne H, Brunet E, Mercher T, Pflumio F |
Molecular cancer | 2024 |
Establishment of the Diagnostic Signature of Ferroptosis Genes in Multiple Sclerosis.
Yang Y, Bai Q, Liu F, Zhang S, Tang W, Liu L, Xing Z, Wang H, Zhang C, Yang Y, Fan H |
Biochemical genetics | 2024 |
Acute Myeloid Leukemia: Diagnosis and Evaluation by Flow Cytometry
Ally F, Chen X |
Cancers | 2024 |
Proliferative verrucous and homogeneous Leukoplakias exhibit differential methylation patterns
Herreros\u2010Pomares A, Hervás D, Bagán L, Proaño A, Bagan J |
Oral Diseases | 2024 |
Aptamer-programmable adeno-associated viral vectors as a novel platform for cell-specific gene transfer
Puzzo F, Zhang C, Powell Gray B, Zhang F, Sullenger BA, Kay MA |
2023 | |
Transcriptomic Approaches in Studies on and Applications of Chimeric Antigen Receptor T Cells
Pierzynowska K, Gaffke L, Zaucha JM, Węgrzyn G |
Biomedicines | 2023 |
Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development.
Li J, Kalev-Zylinska ML |
Frontiers in Cell and Developmental Biology | 2023 |
Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination
Lehner KM, Gopalakrishnapillai A, Kolb EA, Barwe SP |
Cancers | 2023 |
CBFA2T3::GLIS2‐positive acute leukemia with RAM and mixed T/megakaryocytic phenotype
Khanlari M, Wang L, Bolen CY, Otanez FS, Furtado LV, Key L, Irwin L, Wang W, Klco JM |
2023 | |
Relapsed pediatric acute myeloid leukaemia: state-of-the-art in 2023.
Egan G, Tasian SK |
Haematologica | 2023 |
Targeted Therapies in Pediatric Acute Myeloid Leukemia - Evolving Therapeutic Landscape.
Al-Antary ET, Gupte A, Ravindranath Y |
The Indian Journal of Pediatrics | 2023 |
Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
Tigu AB, Constantinescu CS, Teodorescu P, Kegyes D, Munteanu R, Feder R, Peters M, Pralea I, Iuga C, Cenariu D, Marcu A, Tanase A, Colita A, Drula R, Bergthorsson JT, Greiff V, Dima D, Selicean C, Rus I, Zdrenghea M, Gulei D, Ghiaur G, Tomuleasa C |
Journal of Cellular and Molecular Medicine | 2023 |
Children's Oncology Group's 2023 blueprint for research: myeloid neoplasms
Cooper TM, Alonzo TA, Tasian SK, Kutny MA, Hitzler J, Pollard JA, Aplenc R, Meshinchi S, Kolb EA |
Pediatric Blood & Cancer | 2023 |
Emerging and Future Targeted Therapies for Pediatric Acute Myeloid Leukemia: Targeting the Leukemia Stem Cells.
Murphy LA, Winters AC |
Biomedicines | 2023 |
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
Gress V, Roussy M, Boulianne L, Bilodeau M, Cardin S, El-Hachem N, Lisi V, Khakipoor B, Rouette A, Farah A, Théret L, Aubert L, Fatima F, Audemard É, Thibault P, Bonneil É, Chagraoui J, Laramée L, Gendron P, Jouan L, Jammali S, Paré B, Simpson SM, Tran TH, Duval M, Teira P, Bittencourt H, Santiago R, Barabé F, Sauvageau G, Smith MA, Hébert J, Roux PP, Gruber TA, Lavallée VP, Wilhelm BT, Cellot S |
Blood Advances | 2023 |